The duration of expression of the gene Cdx2 is tightly regulated by a newly identified DNA sequence element called an ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle ...

Vetter has invested approximately $285 million in the new Des Plaines clinical manufacturing site, which is expected to open in late 2029.

A membrane transport protein called SLC13A5 has previously been linked to a severe form of epileptic encephalopathy.

Using the ProFoundry platform and Novartis' expertise, the partners will identify novel proteins and drug targets for cardiovascular disease.

Labviva connects pharmaceutical R&D labs directly to 90% of all raw materials suppliers available in the United States and Europe.

When the macrophages’ ability to consume dying cancer cells or Upd3 production was decreased, tumor growth was significantly ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts ...

The SAIR database is designed to help scientists train AI models to better predict protein-ligand binding affinities for drug ...

The company has integrated the AI model into its internal discovery pipeline and aims to use it in collaborative drug ...

AI-powered ChemPerturb-seq reveals sex-specific cocktail improving islet transplant survival, offering a new treatment for ...

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...